The Italian Competition Authority targets a bid-rigging practice concerning supply of plasma derived drugs
Combating bid-rigging practices affecting public procurement contracts in the health sector is always a high priority for the Italian Competition Authority (ICA), as reflected by its recent decision to open an antitrust investigation in the case I819 ( Gara per produzione e fornitura al sistema sanitario di farmaci plasma derivati, http://www.agcm.it/component/joomdoc/allegati-news/I819_avvio.pdf/download.html ). This time, in the case I819, the ICA considered the joint bidding of two manufacturers, Kedrion and Grifols, for the contracts for the supply of plasma derived to the health system of the region of Emilia Romagna (HSER). The temporary association of undertakings set up by Kedrion and Grifols (RTI) was the awardee of the supply contract. As is known, temporary associations of undertakings can be lawfully used for jointly bidding if its members cannot qualify for make single bids. However, in the case I819 the ICA had concern that the joint bidding of Kedrion and Grifols t...